Genmab A/S SEC filings GNMSF
Genmab A/S has 566 filings in SEC EDGAR's recent list, going back to Apr 28, 2008. Its latest annual report, Form 20-F, was filed on Feb 17, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Feb 17, 2026 | Dec 31, 2025 |
| 20-F | Annual report (foreign issuer) | Feb 12, 2025 | Dec 31, 2024 |
| 20-F | Annual report (foreign issuer) | Feb 14, 2024 | Dec 31, 2023 |
| 20-F | Annual report (foreign issuer) | Feb 22, 2023 | Dec 31, 2022 |
| 20-F | Annual report (foreign issuer) | Feb 16, 2022 | Dec 31, 2021 |
| 20-F | Annual report (foreign issuer) | Mar 29, 2021 | Dec 31, 2020 |
| 20-F | Annual report (foreign issuer) | Mar 30, 2020 | Dec 31, 2019 |
| ARS | Annual report to shareholders | Apr 28, 2008 | Dec 31, 2006 |
| ARS | Annual report to shareholders | Apr 28, 2008 | Dec 31, 2007 |
Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GMAB (Nasdaq), GNMSF (OTC)
- Headquarters
- 1253 Copenhagen K, Denmark
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1434265
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.